-
Animal & Veterinary
-
Draft Risk Assessment and the Establishment of Resistance Thresholds Workshop
December 9-10, 1999
-
Meeting Materials
-
-
December 9th Meeting Transcripts
- Welcome and Outline of Scope, Purpose and Objectives of Workshop
Dr. Andrew Beaulieu, FDA, Deputy Director, Center for Veterinary Medicine - Introductions
Dr. Stephen Sundlof, FDA, Director, Center for Veterinary Medicine - What is Risk Assessment, Risk Management and Risk Communication
Wesley Long, Ph.D., FDA, Associate Scientific Director, JIFSAN - Use of Risk Assessment in Regulatory Decision-Making
Lester Crawford, C.V.M., Ph.D., Georgetown University Director, Center for Food & Nutrition Policy - The Importance of Risk Communication in the Development of Science-Based Regulatory Requirements
Douglas Powell, Ph.D., University of Guelph, Department of Plant Agriculture - Antibiotic Breakpoints: Methods for Determining and Use by Medical Community
Dr. Al Sheldon, FDA, Center for Drug Evaluation Research - Antibiotic Breakpoints: Methods for Determining and Use by Veterinary Medical Community
Dr. Tom Shryock, Elanco Animal Health - Epidemiology of Campylobacter in Humans
Kirk Smith, D.V.M., Ph.D., Minnesota Department of Health - Epidemiology of Campylobacter in Animals
Dr. Paula J. Fedorka-Cray, US Department of Agriculture Animal Research Service - Presentation of CVM Risk Assessment
Dr. David Vose, Risk Consultancy - Mathematical Validity of CVM Risk Assessment
Dr. Tony Cox, Cox Associates - Challenges in Assessing and Regulating the Risk of Antimicrobial Use
Dr. Stephen Sundlof, FDA, Center for Veterinary Medicine - Session 1: Use of Risk Assessment to Evaluate Human Health Impact of Resistant Pathogens
Chair: Wesley Long, Ph.D. - Using Risk Assessment to Evaluate the Human Health Impact of Resistant Pathogens
Dr. Scott McEwen, University of Guelph, Ontario Veterinary College - Georgetown Risk Assessment
Dr. Steve Anderson, US Department of Agriculture, FSIS-AAAS - EMEA Risk Assessment
Dr. Louise Kelly, Veterinary Laboratories Agency, Department of Risk Research - CVM Risk Assessment: Assumptions and Uncertainties
Dr. Kathy Hollinger and Mary Bartholomew, FDA, Center for Veterinary Medicine - Panel Discussions on CVM RA Model
- Questions/Comments for Panel
- Public Comment Period
-
-
December 10th Meeting Transcripts
- Introduction
Keith Sterner, D.V.M., VMAC - Assessment of Risk: Food Additives
Alan Rulis, Ph.D., FDA, Center for Food Safety and Applied Nutrition - Assessment of Risk: Drug Residues
Kevin Greenlees, Ph.D., FDA, Center for Veterinary Medicine - Assessment of Risk: Pesticides
Roy Sjoblad, Ph.D., US Environmental Protection Agency Office of Pesticide Programs - Assessment of Risk: Microbiological Risks
Dick Whiting, Ph.D., U.S. Environmental Protection Agency - Assessment of Risk: Water
Steve Shaub, Ph.D., U.S. Environmental Protection Agency Office of Science and Technology - Assessment of Risk: Pathogens on Meat
Kenneth Petersen, Ph.D., USDA Food Safety Inspection Service - Human Health Impact from Food-borne Disease
Kenneth Petersen, Ph.D. USDA Food Safety Inspection Service - Human Health Impact of Resistant Food-borne Disease
J. Glenn Morris, Jr., M.D., University of Maryland Medical School Department of Epidemiology and Medicine - Interpreting and Weighing Risk
J. Glenn Morris, Jr., M.D., University of Maryland Medical School Department of Epidemiology and Medicine - Evaluating Risk from Resistant Pathogens under FFDCA
Linda Tollefson, D.V.M., FDA Center for Veterinary Medicine - Panel Discussion: How Should CVM Evaluate Risk from Resistant Pathogens
- Questions/Comments to the Panel Assessment of Risk: Contaminants
Dr. Michael Bolger, Center for Food Safety and Applied Nutrition - Public Comment Period
- Setting Thresholds and Next Steps
Dr. Sharon Thompson, FDA Center for Veterinary Medicine
-
-
-